Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    18398081 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed EPANOVA in Crohn's Disease, Study 1
Condition: Crohn's Disease
Intervention: Drug: Epanova
2 Completed An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Epanova™ (Omega-3 Free Fatty Acids)

Study has passed its completion date and status has not been verified in more than two years.